Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFranchise Brands Regulatory News (FRAN)

Share Price Information for Franchise Brands (FRAN)

Share Price is delayed by 15 minutes
Get Live Data
142.00    0.00 (0.00%)
Bid:
143.00
Ask:
148.00
Spread: 5.00 (3.497%)
Market Cap: £272.19m
FRAN Live PriceLast checked at - London Stock Exchange

Intraday Franchise Brands Share Chart

Share Purchase Programme

24 Jun 2022 16:45

RNS Number : 1858Q
Franchise Brands PLC
24 June 2022
 

24 June 2022

FRANCHISE BRANDS PLC

("Franchise Brands", "the Group" or "the Company")

 

Share purchase programme

 

Franchise Brands plc (AIM: FRAN), an international multi-brand franchise business, announces that it will continue its discretionary programme to buy ordinary shares of 0.5p each in the Company ("Ordinary Shares") for the next six-month period from 1 July 2022 to 31 December 2022, up to an aggregate value of £1,500,000 (the "Programme").

The Trustee of the Franchise Brands PLC Employee Benefit Trust (the "EBT") will purchase Ordinary Shares in accordance with the Programme. The Programme seeks to mitigate the dilutive impact of share option awards and to improve overall shareholder return.

During the period 1 January 2022 to 24 June 2022 ("H1 2022"), the EBT has purchased 427,469 Ordinary Shares at an average price of 139 pence per share. 110,921 Ordinary Shares held by the EBT have been used to satisfy the exercise of options over Ordinary Shares. Accordingly, the EBT currently holds 535,788 Ordinary Shares (31 December 2021: 219,240 Ordinary Shares) which represents 0.41 per cent. (31 December 2021: 0.23 per cent.) of the Company's current issued share capital. The net cash cost to the Company during H1 2022 was £445,552.

The Trustees of the EBT have entered into arrangements with the Company's joint broker, Dowgate Capital Limited ("Dowgate"), to carry out on-market purchases of Ordinary Shares under the Programme, including on a discretionary basis independent of the Company during any prohibited periods of the Company, as determined by the UK Market Abuse Regulation, which may fall during the period of the Programme.

 

Enquiries:

Franchise Brands plc

+ 44 (0) 1625 813231

Stephen Hemsley, Executive Chairman

Brian Hogan, Chief Financial Officer

Julia Choudhury, Corporate Development Director

 

Allenby Capital Limited (Nominated Adviser and Joint Broker)

+44 (0) 20 3328 5656

Jeremy Porter / Liz Kirchner (Corporate Finance)

Amrit Nahal (Sales and Corporate Broking)

 

Dowgate Capital Limited (Joint Broker)

+44 (0) 20 3903 7715

James Serjeant / Colin Climie / Nicholas Chambers

 

MHP Communications (Financial PR)

+44 (0) 20 3128 8100

Katie Hunt / Catherine Chapman

+44 (0) 7884 494112

 

franchisebrands@mhpc.com

 

 About Franchise Brands plc

Franchise Brands is focused on building market-leading businesses in selected customer segments, primarily via a franchise model. The Group currently has a combined network of over 600 franchisees across six principal franchise brands in the UK, North America and Europe. Our focus is on established brands which can benefit from our shared support services, specialist sector expertise, management experience and group resources.

Our B2B brands are Metro Rod, Metro Plumb, Filta, Willow Pumps and Azura, and our principle B2C brands are ChipsAway, Ovenclean and Barking Mad. Each of our brands are leaders in their respective markets. The combined trading history of all the Group's brands is over 190 years. Franchise Brands employs over 430 people from 5 principal offices in the UK as well as Orlando, Florida and the Netherlands.

 

For further information, visit www.franchisebrands.co.uk .

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFLFVERTISFIF
Date   Source Headline
7th Dec 20217:00 amRNSDirectorate Change
29th Nov 20217:00 amRNSAcquisition of Azura & total voting rights
22nd Nov 20217:00 amRNSDirector/PDMR Shareholding
2nd Nov 20217:00 amRNSDirector/PDMR Shareholding
26th Oct 20217:00 amRNSQ3 Trading Update
12th Oct 20217:00 amRNSDirector/PDMR Shareholding
24th Sep 20217:00 amRNSThe Global Group UK Investor Summit
22nd Jul 20217:00 amRNSInterim Results
5th Jul 20217:00 amRNSTrading Update and Notice of Interim Results
1st Jul 20217:00 amRNSShare purchase programme
16th Jun 20212:06 pmRNSSecond Price Monitoring Extn
16th Jun 20212:00 pmRNSPrice Monitoring Extension
16th Jun 20217:29 amRNSDirector/PDMR Shareholding
9th Jun 20217:00 amRNSDirector/PDMR Shareholding
25th May 20217:00 amRNSLockdown easing leads to record job numbers
20th Apr 202111:34 amRNSResult of AGM
20th Apr 20217:00 amRNSAGM Statement and Trading Update
4th Mar 20217:00 amRNSFinal Results
24th Feb 20217:00 amRNSInvestor Presentation
18th Feb 20217:00 amRNSInvestor Presentation
25th Jan 20217:00 amRNSHolding(s) in Company
12th Jan 20217:00 amRNSTrading Update and Notice of Full Year Results
31st Dec 20207:00 amRNSShare purchase programme
10th Nov 20207:00 amRNSDirector/PDMR Shareholding
30th Oct 20205:00 pmRNSTotal Voting Rights
28th Oct 20202:01 pmRNSDirector/PDMR Shareholding
28th Oct 20207:00 amRNSQ3 Trading Update
28th Sep 20207:00 amRNSDirector shareholdings, issue of equity & TVR
22nd Sep 20207:00 amRNSDirector/PDMR Shareholding
21st Sep 20207:00 amRNSDirector/PDMR Shareholding
16th Sep 20207:00 amRNSGrant under New Share Option Scheme, PDMR Dealings
30th Jul 20207:00 amRNSInterim Results
7th Jul 20207:00 amRNSNotice of Results
1st Jul 20207:00 amRNSShare purchase programme and EBT
30th Jun 20205:00 pmRNSTotal Voting Rights
25th Jun 20207:00 amRNSExercise of Options and Other Matters
9th Jun 20204:00 pmRNSDirectors’ shareholdings
3rd Jun 20207:00 amRNSResult of scrip dividend and change to TVR
22nd May 20204:42 pmRNSHolding(s) in Company
1st May 20205:10 pmRNSHoldings in Company and director’s holding
30th Apr 20205:00 pmRNSTotal Voting Rights
30th Apr 202010:40 amRNSHolding(s) in Company
29th Apr 20209:00 amRNSHolding(s) in Company
28th Apr 20203:05 pmRNSHolding(s) in Company
28th Apr 202011:19 amRNSResult of Annual General Meeting
28th Apr 20208:30 amRNSHoldings in Company and director’s holding
27th Apr 202012:00 pmRNSHolding(s) in Company
21st Apr 202012:44 pmRNSResult of Bookbuild
20th Apr 20204:38 pmRNSProposed Placing and Trading Update
7th Apr 20207:00 amRNSBoard & senior management scrip dividend election

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.